Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03451825
Title Phase I/II Study of Avelumab in Pediatric Cancer Subjects
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors EMD Serono Research & Development Institute, Inc.
Indications
Therapies
Age Groups: adult | child
Covered Countries USA | DNK | CAN | BEL


No variant requirements are available.